Proto Labs, Inc.
PRLB
$57.59
$0.250.44%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 533.13M | 518.38M | 508.64M | 499.21M | 500.89M |
| Total Other Revenue | -- | 206.00K | 487.00K | 596.00K | 756.00K |
| Total Revenue | 533.13M | 518.38M | 508.64M | 499.21M | 500.89M |
| Cost of Revenue | 295.99M | 289.66M | 283.98M | 277.77M | 277.69M |
| Gross Profit | 237.14M | 228.72M | 224.66M | 221.43M | 223.20M |
| SG&A Expenses | 168.13M | 163.99M | 161.13M | 157.53M | 156.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 506.93M | 495.83M | 486.36M | 476.04M | 475.39M |
| Operating Income | 26.20M | 22.55M | 22.28M | 23.16M | 25.50M |
| Income Before Tax | 31.06M | 22.63M | 22.25M | 22.93M | 24.67M |
| Income Tax Expenses | 9.82M | 7.79M | 7.43M | 8.01M | 8.08M |
| Earnings from Continuing Operations | 21.24 | 14.84 | 14.81 | 14.92 | 16.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.24M | 14.84M | 14.81M | 14.92M | 16.59M |
| EBIT | 26.20M | 22.55M | 22.28M | 23.16M | 25.50M |
| EBITDA | 60.34M | 57.40M | 57.61M | 58.89M | 61.63M |
| EPS Basic | 0.89 | 0.62 | 0.61 | 0.60 | 0.66 |
| Normalized Basic EPS | 0.84 | 0.74 | 0.71 | 0.72 | 0.75 |
| EPS Diluted | 0.88 | 0.61 | 0.60 | 0.60 | 0.65 |
| Normalized Diluted EPS | 0.83 | 0.73 | 0.71 | 0.72 | 0.75 |
| Average Basic Shares Outstanding | 95.69M | 96.40M | 97.49M | 98.90M | 100.39M |
| Average Diluted Shares Outstanding | 96.90M | 97.20M | 98.03M | 99.31M | 100.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |